AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06768268 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Voluven-assisted Indocyanine green fluorescence guided sentinel lymph node biopsy for breast cancer
Description: The procedure includes: (1) preparation of specific formula of ICG:Voluven solution (2) injection of ICG solution at subarelar area or peri-tumoral area (3) observation of fluorescent lymphatic drainage and retrieval of sentinel lymph nodes
Study NCT06768268 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mannitol (20%)
Description: Adding Mannitol into Voluven and used as solvent of ICG
Study NCT06769672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: active tDCS with dual-task training
Description: participants receive three 20-minute active tDCS treatment and three 60-minute COGMOTION dual-task exercise sessions per week for four consecutive weeks.
Study NCT06769672 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sham tDCS with dual-task training
Description: participants receive three 20-minute sham tDCS treatment and three 60-minute COGMOTION dual-task exercise sessions per week for four consecutive weeks.
Study NCT06769230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core strengthening exercise
Description: The participants will perform warm-up exercises including Cat and Camel, spinal movement (spinal flexion and extension cycles), and stretching exercises for the calf, hamstrings, quadriceps and lower back for about 5 minutes. After that, the women will be asked to perform core stability exercises including abdominal hollowing, bilateral knee raise, supine extension Bridge, straight leg rise from prone and alternate arm and leg raise from quadruped. Each exercise will be repeated for 10 times with 7-8 seconds hold and will be increased by four repetitions each week throughout the interventions. During each repetition for every exercise, the patient will be asked to contract her abdominal muscles and maintain this contraction while maintaining her normal breathing pattern.
Study NCT06769230 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core strengthening exercise
Description: The participants will perform warm-up exercises including Cat and Camel, spinal movement (spinal flexion and extension cycles), and stretching exercises for the calf, hamstrings, quadriceps and lower back for about 5 minutes. After that, the women will be asked to perform core stability exercises including abdominal hollowing, bilateral knee raise, supine extension Bridge, straight leg rise from prone and alternate arm and leg raise from quadruped. Each exercise will be repeated for 10 times with 7-8 seconds hold and will be increased by four repetitions each week throughout the interventions. During each repetition for every exercise, the patient will be asked to contract her abdominal muscles and maintain this contraction while maintaining her normal breathing pattern.
Study NCT06769230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory motor training
Description: The participants will perform warm-up exercises including neck rotations, arm circles, ankle rotations, trunk rotations, trunk bending and extending for 5-10 mins. After warm up the women performs Bosu ball exercises including Bosu ball one Leg Bridge, Bosu Crunch, Bosu Sit ups, Bosu compressions, Bosu side crunch and Bosu bodyweight squat . Each exercise will be repeated for 6 repetitions in each set. At least 3 sets of each exercise are performed per session. Each exercise will be increased by five repetitions each week throughout the interventions.The total duration of each session is 45 minutes.
Study NCT06769555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM-336 BCMA/CD3 bispecific antibody
Description: Patients received subcutaneous CM-336 80 mg once weekly in 28-d cycles after two step-up priming doses of 3 mg and 20 mg given on day 1 and day 4 of cycle 1. For patients achieve hematological PR or better after 2 cycles, and hematological VGPR or better after 4 cycles, the treatment regimen will change to 160mg once every 2 weeks (Q2W).
Study NCT06768034 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intervention Group
Description: Patients being referred to an internist or cardiologist after myocardial injury after noncardiac surgery
Study NCT06769334 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PLAY Program
Description: The PLAY Program is a web-based program created for caregivers of childhood cancer survivors. The program consists of seven modules with the following topics: 1) Introduction to the program 2) Self-Care 3) Relationships 4) Getting Ready for School 5) Talking, Reading, and Counting together 6) Social and Emotional Development 7) Review Module. The program is meant to be completed over approximately three months, and caregivers in the program will meet with a coach on a weekly or bi-weekly basis to discuss what they learned in the modules and how to practice it in their daily lives.
Study NCT06767670 — intervention group
Intervention type: OTHER
Intervention: stainless steel crown
Description: familiar method of managing multi-surface carious lesions in primary teeth
Study NCT06767670 — intervention group
Intervention type: OTHER
Intervention: bioflex crown
Description: aesthetic preformed pediatric crowns that offer the properties of both stainless steel and zirconia crowns
Study NCT06769009 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational intervention measures on iodine, iodine deficiency and iodine intake
Description: The intervention consist of an educational intervention which will educate the young women on the importance of iodine, the consequences of iodine deficiency, dietary iodine sources and the iodine in pregnancy. The educational intervention consist of four intervention components: an iodine feedback tool, and educational iodine conversation with a healthcare professional, an iodine factsheet and an iodine video. The healthcare professionals who carry out the educational conversation will receive a specially designed training program.
Study NCT06767878 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PORTiSOFIE
Description: This treatment is based on the Clark and Wells model of social phobia, and it is constituted by 9 modules:~1. Introduction of the program and overview of social anxiety disorder and symptoms~2. Negative automatic thoughts~3. Challenging negative automatic thoughts~4. Behavioral experiments~5. Exposure~6. Exposure and self-focus attention~7. Exposure and get closer to fears~8. Social skill training~9. Maintenance plan
Study NCT06767878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PORTiSOFIE
Description: This treatment is based on the Clark and Wells model of social phobia, and it is constituted by 9 modules:~1. Introduction of the program and overview of social anxiety disorder and symptoms~2. Negative automatic thoughts~3. Challenging negative automatic thoughts~4. Behavioral experiments~5. Exposure~6. Exposure and self-focus attention~7. Exposure and get closer to fears~8. Social skill training~9. Maintenance plan
Study NCT06769061 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Patients will receive 6 weeks of electroacupuncture, 2 sessions per week, 30 min per session Stainless steel, single-use, sterile, and disposable needles will be used. We will use the bilateral acupoints LI4 (He-Gu), TE5 (Wai-Guan), LI11 (Qu-Chi), and LU5 (Chi-Ze) for upper limbs. For lower limb numbness, we will use the bilateral acupoints of LV3 (Tai-Chong), ST41 (Jie-Xi), SP6 (San-Yin-Jiao), and GB34 (Yang-Ling-Quan) for the numbness of back of feet, or the bilateral acupoints of KI1 (Yong-Quan), KI3 (Tai-Xi), SP6 (San-Yin-Jiao), and GB34 (Yang-Ling-Quan). After skin disinfection, sterile adhesive pads will be placed on bilateral LI4 (Hegu), TE5 (Waiguan), LI11 (Quchi), and LU5 (Chize). Following each needle insertion, acupuncturists will perform equal manipulations of twirling, lifting, and thrusting on the needle by acupuncturists to achieve the de qi sensation. These 4 acupoints (He-Gu, Qu-Chi, San-Yin-Jiao, Yang-Ling-Quan) will be electrically stimulated for 30 min.
Study NCT06769061 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham acupuncture
Description: Patients will receive 6 weeks of sham acupuncture, 2 sessions per week, 30 min per session. The Streitberger sham acupuncture needle designed specifically for sham acupuncture trials will be used. Patients will feel the needle on the skin, but the needle actually will not puncture the skin. These 4 acupoints (He-Gu, Qu-Chi, San-Yin-Jiao, Yang-Ling-Quan) will be connected to the electrical stimulation device KWD-808I MULTI-PURPOSE Health device (Great Wall Company), but not stimulated. The needle will remain for 30 minutes. without stimulating the acupoints. The sham acupuncture will be used within the trocar. The trocar will be fixed by a base on the skin with sticker. The trocar-base-sticker will be used for both acupuncture group and sham acupuncture control group, so they are exactly the same in appearance. Patients cannot see if there is acupuncture or sham acupuncture within the trocar.
Study NCT06769893 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 68Ga-NOTA-RCCB6 PET/CT Scan
Description: The imaging agent 68Ga-NOTA-RCCB6 used in this project is synthesized following the standards for radiopharmaceutical production, with reference to the Chinese Pharmacopoeia (quality standards for 18F-FDG). The pH value is between 5.0 and 8.0; the radiochemical purity is not less than 95%, and the bacterial endotoxin content in each milliliter of solution is less than 15EU; the radioactive concentration is not less than 37 MBq/mL; the solvent residues comply with the regulations.~Specification: 185\~1850 MBq/ml Characteristics: Clear, colorless, no visible particles. Radioactive physical half-life: 68Ga is 68 minutes. Expiry: Calculated from the time of labeling, stable for 3 half-lives. Administration method: Intravenous injection. Dosage: 0.05-0.1mCi/kg, flush with 5 mL of saline after injection. The maximum mass dose of CD70 should not exceed 240ug, and the maximum volume of administration should not exceed 5 mL.
Study NCT06768177 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRP injection
Description: 3 ML OF PRP
Study NCT06768177 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alprostadil 20 micrograms
Description: 1 ML
Study NCT06764966 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin 20 mg
Description: Atorvastatin 20 mg Once Daily with previously prescribed Non Selective Beta-Blocker
Study NCT06764966 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Once Daily along with previously prescribed Non Selective Beta Blocker
Study NCT06766019 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab combined with irinotecan liposomal (II), oxaliplatin, and 5-FU/LV
Description: 1. adebrelimab 1200mg, i.v. D1, q28d~2. irinotecan liposomal (II) 60mg/m\^2, i.v. D1, Q2W~3. oxaliplatin 85mg/m\^2, i.v. D1, Q2W~4. 5-FU/LV 2400mg/400mg/m\^2, i.v. D1, Q2W 4-week cycles, 6 cycles
Study NCT06769958 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reflexology
Description: Reflexology application
Study NCT06769217 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Drug Eluting Coronary Stent
Description: The Drug Eluting Coronary stent is indicated for the treatment of de novo coronary artery lesions in patients with symptomatic ischemic heart disease.
Study NCT06767475 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care
Study NCT06767475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discussion
Description: Attend a focus group
Study NCT06767475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion
Description: Participate in group discussion with exercises and activities
Study NCT06767475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Attend a one-on-one interview
Study NCT06767475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06767475 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06764953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-GRAFT ™
Description: E-GRAFT™ that is a dehydrated thick amniotic allograft processed and approved for use as a Human Cellular and Tissue-Based Product (HCT/P) under FDA 21 CFR 1271 and Section 361 of the Public Health Service (PHS) Act.
Study NCT06764953 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FIBRACOL™
Description: 510K FDA cleared Collagen alginate dressing
Study NCT06768645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetic foot care education delivered using the Pecha Kucha method
Description: The study commenced after obtaining ethical approval and written consent from the relevant institution. The Pecha Kucha presentation was prepared by the researcher, adhering to established literature and the specific requirements of the technique. The education covered six key topics: 1) Diabetes and Foot Problems, 2) Daily Foot Care, 3) Appropriate Socks, 4) Appropriate Footwear, 5) Nail Care, and 6) Daily Life Precautions. Expert opinions were sought from four academics (S.Ö; K.L; Z.Z; G.F) with expertise in the field to establish content validity for the final version of the Pecha Kucha diabetic foot care presentation. Following expert approval, a pilot study was conducted with 10 diabetic patients who met the sample group criteria. Feedback from these patients regarding system functionality, clarity, and flow was incorporated to finalize the presentation. Afterward, the finalized Pecha Kucha Information training was delivered to the experimental group. The presentations were cond
Study NCT06768645 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: traditional diabetic foot care education
Description: traditional diabetic foot care education
Study NCT06767657 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CEA (carotid endarterectomy)
Description: Intervention (CEA) is associated to both arms (group A and B)
Study NCT06767657 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CEA (carotid endarterectomy)
Description: Intervention (CEA) is associated to both arms (group A and B)
Study NCT06769022 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal Setting and Exercise Intensity Intervention
Description: Participants' goal-setting and exercise intensity are manipulated based on group assignment.
Study NCT06766682 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Skill Development Program for Emotion Regulation
Description: The Skill Development Program for Emotion Regulation to be carried out with the intervention group was planned as 6 sessions. The aim of this study was to investigate The Skill Development Program for Emotion Regulation Program on oncology nurses' emotion regulation difficulties, emotion regulation skills, experiential avoidance, and compassion fatigue.
Study NCT06764901 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Therapy Chat Service (TCS)
Description: Online Therapy Chat Service (TCS) based on CBT techniques from the Berlin Dissexuality Therapy (Beier, K. M. (2021). Pedophilia, hebephilia and sexual offending against children. The Berlin Dissexuality Therapy (BEDIT). Springer).
Study NCT06765746 — intervention group
Intervention type: PROCEDURE
Intervention: Ventricular tachycardia ablation
Description: All ventricular tachycardia (VT) ablation procedures will be performed under general anesthesia. An epicardial approach will be performed, if clinically needed, when a detailed endocardial mapping during VT fails to reveal the complete VT critical isthmus. In case of epicardial mapping, the pericardium will be accessed percutaneously using the method described by Sosa et al.~VT activation mapping will be performed and the critical isthmus will be defined as the diastolic pathway.~Ablation will be performed at 50 W (temperature limit of 43 °C) using an irrigated ablation catheter (TactiFlex, Abbott, MN). Ablation will be aimed at VT isthmus transection. Substrate modification will be added if the patient is still inducible or in the absence of any inducible/tolerated VT. Substrate ablation will be performed based on sinus rhythm mapping, aiming at non-inducibility of any VT. At the end of procedure, programmed ventricular stimulation will be repeated.
Study NCT06766110 — intervention group
Intervention type: OTHER
Intervention: Assessment
Description: 31 volunteer participants who were followed up at the Department of Chest Diseases, Istanbul University, Istanbul Faculty of Medicine and met the inclusion criteria were included in the study. Participants' body composition, upper extremity functional exercise capacity, grip strength, and activities of daily living were evaluated.
Study NCT06768255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate (II)+ prednisolone (5mg bid) +ADT
Description: Abiraterone Acetate（II）
Study NCT06768255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abiraterone acetate 1000 mg + prednisolone (5mg bid) +ADT
Description: Abiraterone acetate 1000 mg
Study NCT06766006 — intervention group
Intervention type: PROCEDURE
Intervention: Venoarterial extracorporeal life support (VA ECLS) implant
Description: Implantation of venoarterial extracorporeal life support implant for refractory cardiogenic shock or cardiac arrest of any cause.
Study NCT06767215 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ice Compress
Description: Ice compress will be applied 5 minutes before butulinium injection
Study NCT06767215 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No ice compress
Description: No ice compress will be applied .
Study NCT06765993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isosorbide oral solution
Description: 30 mL, TID
Study NCT06765993 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 30 mL, TID
Study NCT06766877 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability exercise
Description: 1. Isometric quadriceps exercises involving knee extension~2. Maximum isometric exercise for the quadriceps
Study NCT06766877 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: foot-ankle strengthening exercise
Description: 1. Isometric quadriceps exercises involving knee extension~2. Maximum isometric exercise for the quadriceps
Study NCT06765369 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet
Description: The MD is characterized by increased consumption of legumes, whole grains, vegetables, fruits, nuts, seeds and olive oil, moderate consumption of fish, poultry and dairy foods, with low consumption of processed foods and red meat. The nutritional profile of the MD intervention will consist of 46% carbohydrates, 17% protein, and 35% fat. A significant focus on dietary fat consumption with maintaining an omega 6:3 ratio of approximately 3:1 or lower. The MD will provide fibre-rich foods to meet the fibre recommendations for Canadians (males: 30 grams/day, females: 21 grams/day)
Study NCT06765369 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Westernized Diet
Description: The WD is characterized by increased consumption of highly processed foods, refined grains, red meats, processed meats, added sugars, added salt, high intake of omega-6 PUFA, accompanied by a reduction in fibre, fruits and vegetables, whole grains, fish, as well as nuts and seeds.The nutrition composition of the WD intervention will consist of 46% of calories derived from refined carbohydrates and added sugars, 17% protein (sourced from red and processed meats) and 35% fat. The fatty acid profile will be characterized by higher amounts of n-6 PUFAs while lacking in n-3 PUFAs and MUFAs, with a omega 6:3 ratio of 15-20:1.
Study NCT06765967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: displaying virtual reality images
Description: Patients were shown content filmed in 4K resolution through the glasses.
Study NCT06765967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: music playback
Description: With the permission of the Turkish Music Research and Promotion Group (TÜMATA), 'Acemaşiran Makamı' was played.
Study NCT06765239 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hayfever Care
Description: Powdered natural food supplement provided as a decoction, to be taken twice daily.~Personalized Diet and Nutrition Guidance along with Lifestyle Advice
Study NCT06765239 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Wait-list Control
Description: Personalized Diet and Lifestyle Advice
Study NCT06765187 — intervention group
Intervention type: BIOLOGICAL
Intervention: RIV3
Description: intramuscular injection
Study NCT06768684 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief behavioral counseling
Description: Participants receive a two-session phone-based alcohol risk reduction intervention based on principles of harm reduction. Participants receive personalized feedback regarding how alcohol use may impact their health. Following a motivational enhancement exercise, participants are advised to reduce alcohol intake to within recommended limits. Evidence-based strategies are discussed (e.g., goal setting, self-monitoring, identifying and avoiding triggers, dealing with urges, pacing and spacing drinks, managing high risk situations, finding alternatives to alcohol, developing refusal skills, and enlisting social support). Educational materials addressing methods for cutting down are also provided, along with information about other available resources to support their efforts.